Effectiveness of psychopharmacology in Anorexia Nervosa treatment

1. Bissada H. et al.: Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry, 165, 10,2008.10.1176/appi.ajp.2008.07121900Search in Google Scholar

2. Court A. et al.: Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: a pilot study. J Psychiatr Res., 44, 15, 2010.Search in Google Scholar

3. Hagman J. et al.: A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study. J Am Acad Child Adolesc Psychiatry, 50, 9, 2011.Search in Google Scholar

4. Kaye W.H. et al.: Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry, 2001 49, 7, 2001.10.1016/S0006-3223(00)01013-1Search in Google Scholar

5. Kouidrat Y. et al.: Eating disorders in schizophrenia: implications for research and management. Schizophr Res Treatment, 2014.10.1155/2014/791573425107125485152Search in Google Scholar

6. Kracke E.J., Tosh A.K.: Treatment of anorexia nervosa with longterm risperidone in an outpatient setting: case study. Springerplus, 2, 3, 2014.Search in Google Scholar

7. Kucharska-Pietura K. et al.: The recognition of emotion in the faces and voice of anorexia nervosa. Int J Eat Disord., 35, 1, 2004.10.1002/eat.1021914705156Search in Google Scholar

8. Lacey J.H., Crisp A.H.: Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J., 56, 1, 1980.Search in Google Scholar

9. Madden S. et al.: Burden of eating disorders in 5-13-year-old children in Australia. Med J Aust., 20, 8, 2009.10.5694/j.1326-5377.2009.tb02487.x19374611Search in Google Scholar

10. Okita K. et al.: Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series. Annals of General Psychiatry, 12, 7, 2013.Search in Google Scholar

11. Pinhas L. et al.: Incidence and age-specific presentation of restrictive eating disorders in children: a Canadian Paediatric Surveillance Program study. Arch Pediatr Adolesc Med., 165, 10, 2011.10.1001/archpediatrics.2011.14521969390Search in Google Scholar

12. Powers P.S., Klabunde M., Kaye W.: Double-blind placebo-controlled trial of quetiapine in anorexia nervosa. Eur Eat Disord Rev., 20, 4, 2012.Search in Google Scholar

13. Smink F.R., van Hoeken D., Hoek H.W.: Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr Psychiatry Rep., 14, 4, 2012.Search in Google Scholar

14. Strobel M. et al.: Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode - a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements. Z Kinder Jugendpsychiatr Psychother., 32, 4, 2004.10.1024/1422-4917.32.4.27915565897Search in Google Scholar

15. Umehara H., Iga J., Ohmori T.: Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection. Clin Psychopharmacol Neurosci., 12, 1, 2014.Search in Google Scholar

16. Walsh B.T. et al.: Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA, 14, 22, 200610.1001/jama.295.22.260516772623Search in Google Scholar